BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211117T120000
DTEND;TZID=America/Vancouver:20211117T130000
DTSTAMP:20211108T174315Z
CREATED:20211108T174315Z
LAST-MODIFIED:20211108T174315Z
UID:15514-1637150400-1637154000@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nAbstract: \nHeterogeneous treatment effects (HTE) based on patients’ genetic or clinical covariates are of rising interest to precision medicine. Simultaneously modeling HTE and associated main effects for high-dimensional markers is challenging. Motivated by the modified covariate approach\, we propose a two-stage statistical learning procedure for estimating HTE with efficiency augmentation\, exploiting powerful gradient boosting trees (GBT). Target estimands for HTE are defined as the mean difference for quantitative outcomes\, or the risk ratio for binary outcomes\, solving specialized loss functions. The first stage is to estimate the main-effect equivalency of baseline covariates on the outcome\, which is then used as an augmentation term in the second stage estimation for HTE. The proposed two-stage procedure is robust to model mis-specification of main effects and achieve optimal efficiency for estimating HTE through consistent nonparametric function estimation. A permutation test is proposed for the global assessment of high-dimensional HTE via GBT. Simulation experiments and an analysis of a genetic study in Prostate Cancer Prevention Trial are conducted to showcase the properties and the utilities of the two-stage method.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-6/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211117T120000
DTEND;TZID=America/Vancouver:20211117T130000
DTSTAMP:20211108T174315Z
CREATED:20211108T174315Z
LAST-MODIFIED:20211108T174315Z
UID:25806-1637150400-1637154000@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nAbstract: \nHeterogeneous treatment effects (HTE) based on patients’ genetic or clinical covariates are of rising interest to precision medicine. Simultaneously modeling HTE and associated main effects for high-dimensional markers is challenging. Motivated by the modified covariate approach\, we propose a two-stage statistical learning procedure for estimating HTE with efficiency augmentation\, exploiting powerful gradient boosting trees (GBT). Target estimands for HTE are defined as the mean difference for quantitative outcomes\, or the risk ratio for binary outcomes\, solving specialized loss functions. The first stage is to estimate the main-effect equivalency of baseline covariates on the outcome\, which is then used as an augmentation term in the second stage estimation for HTE. The proposed two-stage procedure is robust to model mis-specification of main effects and achieve optimal efficiency for estimating HTE through consistent nonparametric function estimation. A permutation test is proposed for the global assessment of high-dimensional HTE via GBT. Simulation experiments and an analysis of a genetic study in Prostate Cancer Prevention Trial are conducted to showcase the properties and the utilities of the two-stage method.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-6-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211117T120000
DTEND;TZID=America/Vancouver:20211117T130000
DTSTAMP:20211108T174315Z
CREATED:20211108T174315Z
LAST-MODIFIED:20211108T174315Z
UID:26771-1637150400-1637154000@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nAbstract: \nHeterogeneous treatment effects (HTE) based on patients’ genetic or clinical covariates are of rising interest to precision medicine. Simultaneously modeling HTE and associated main effects for high-dimensional markers is challenging. Motivated by the modified covariate approach\, we propose a two-stage statistical learning procedure for estimating HTE with efficiency augmentation\, exploiting powerful gradient boosting trees (GBT). Target estimands for HTE are defined as the mean difference for quantitative outcomes\, or the risk ratio for binary outcomes\, solving specialized loss functions. The first stage is to estimate the main-effect equivalency of baseline covariates on the outcome\, which is then used as an augmentation term in the second stage estimation for HTE. The proposed two-stage procedure is robust to model mis-specification of main effects and achieve optimal efficiency for estimating HTE through consistent nonparametric function estimation. A permutation test is proposed for the global assessment of high-dimensional HTE via GBT. Simulation experiments and an analysis of a genetic study in Prostate Cancer Prevention Trial are conducted to showcase the properties and the utilities of the two-stage method.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-6-3/
LOCATION:Online
END:VEVENT
END:VCALENDAR